Chemed Corporation
NYSEChemed Corporation heads into mid-May with a notable divergence: the stock has recovered 9% over the past month to $419.65, yet the CEO has been a consistent seller throughout the rally — and now short interest has jumped sharply in the past week. The insider angle is hard to ignore. CEO Kevin McNamara sold 2,000 shares on May 1 at $421.13, collecting $842,260. That followed two…
CHE short interest jumped 30.2% over the past week to 3.58% of float, while cost to borrow fell sharply to 0.41%, down 48% in a month.
Snapshot as of 22 Jun 2026
Chemed Corporation heads into mid-May with a notable divergence: the stock has recovered 9% over the past month to $419.65, yet the CEO has been a consistent seller throughout the rally — and now short interest has…
Why this matters — Three distinct ORTEX data streams converged on CHE within days of each other. Short sellers are exiting, options traders are swinging bullish, and borrowing costs have collapsed — all following a…
CHE delivers Q1 results this afternoon with options traders showing rare bullish conviction. Put/call ratio crashed to 0.08, the lowest level in a year, signalling heavy call buying ahead of the print. Short interest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CHE — free to start on ORTEX.
Sign up for free →Open CHE on ORTEX